Skip to content
10-Q

Quarterly Report

NewGen BioPharma Corp.

0001640334-15-000130

← back to feed
Filed
Sep 10, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Sep 8, 2015 11.9M sh
Stockholders Equity Q3 2015 · Jul 31, 2015 −$69.88K
Stockholders Equity Q3 2015 · Oct 31, 2014 −$49.92K
Total Liabilities Q3 2015 · Jul 31, 2015 $69.88K
Total Liabilities Q3 2015 · Oct 31, 2014 $49.92K
Sga Expense Q3 2015 · Jul 31, 2014 $1.4K
Sga Expense Q3 2015 · Jul 31, 2014 $4.51K
Net Income Q3 2015 · Jul 31, 2014 −$5.96K
Net Income Q3 2015 · Jul 31, 2014 −$32.34K
Operating Income Q3 2015 · Jul 31, 2014 −$5.96K
Operating Income Q3 2015 · Jul 31, 2014 −$32.34K